We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Atrium Medical Announces 1-year results of the INFUSE-AMI Trial PR Newswire HUDSON, N.H., May 3, 2013 HUDSON, N.H., May 3, 2013 /PRNewswire/ -- Atrium Medical Corporation, a business unit of...
Thu, Mar 21, 2013 08:00 - Getinge Industrier AB (GNGBY: OTC Link) - Ex-Dividend - As of Fri, Mar 22, 2013, Getinge Industrier AB traded ex-dividend. Getinge Industrier AB will disburse a Cash...
Tue, Mar 12, 2013 08:00 - Getinge Industrier AB (GNGBY: OTC Link) - Scheduled Ex-Dividend - Getinge Industrier AB has announced a dividend ex-date for (GNGBY: OTC Link). Getinge Industrier AB is...
Atrium Medical Corporation showcases ClearWay™ local therapeutic infusion catheter at national program highlighting commitment to healthcare improvement, innovation PR Newswire HUDSON, N.H., June...
GETINGE GROUP and Subsidiary MAQUET Cardiovascular Sign Agreement to Acquire Atrium Medical for $680 Million -- Atrium's products strategically augment MAQUET Cardiovascular's global business...
Atrium Medical Agrees To Be Acquired for $680 Million by GETINGE GROUP PR Newswire HUDSON, N.H., Oct. 3, 2011 HUDSON, N.H., Oct. 3, 2011 /PRNewswire/ -- Atrium Medical Corporation, announced...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.08 | 0.514469453376 | 15.55 | 15.92 | 15.4414 | 55158 | 15.65452337 | DR |
4 | -1.25 | -7.40521327014 | 16.88 | 17.19 | 14.84 | 62334 | 15.5168453 | DR |
12 | -6.455 | -29.2279827938 | 22.085 | 22.85 | 14.84 | 31145 | 16.58571674 | DR |
26 | -2.12 | -11.9436619718 | 17.75 | 22.85 | 14.84 | 23224 | 17.27583962 | DR |
52 | -5.56 | -26.238791883 | 21.19 | 22.85 | 14.84 | 16581 | 17.81848411 | DR |
156 | -28.24 | -64.3720082061 | 43.87 | 44.6 | 14.84 | 23416 | 22.39846173 | DR |
260 | -2.35 | -13.0700778643 | 17.98 | 48.89 | 14.27 | 16786 | 22.82955171 | DR |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions